Brands: Zarontin · Ethosuximide
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Mylan Pharmaceuticals Inc. | generic | 2 | SUPPLYING |
| Parke-Davis Div of Pfizer Inc | unknown | 1 | SUPPLYING |
| PAI Holdings, LLC dba PAI Pharma | unknown | 1 | SUPPLYING |
| Chartwell RX, LLC | generic | 1 | SUPPLYING |
| Chartwell Governmental & Specialty RX, LLC | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup. — Recalling firm: PAI Holdings, LLC. dba Pharmaceutical Associates Inc — Distributed Nationwide in the USA
